Making sure patients get the treatment they need and not a "snake oil" substitute We are at a turning point in regenerative medicine as the first wave of treatments have obtained FDA approval. But at the same time as we see the advance of scientifically rigorous research and regulated products we are also witnessing the … Continue reading Enabling the Best Choice for Patients: The Need for Effective Patient Navigation
Geoff Lomax
How small talk led to a big break; a summer internship at CIRM
At CIRM, California's Stem Cell Agency, we are fortunate to work with some amazing people. This summer we added another name that list when Melissa Cairos joined us for an internship. Melissa is now on to the next part of her adventure, as a policy wonk in Washington DC., but before she left we asked … Continue reading How small talk led to a big break; a summer internship at CIRM
Using the courts to protect patients from unapproved stem cell therapies
A recent article in Nature looked at using lawsuits to help rein in the activities of clinics offering "unapproved" therapies. CIRM's Geoff Lomax explains. When public health officials wanted to raise awareness about the dangers of smoking they filed lawsuits against the tobacco companies. They accused Big Tobacco of deceptive marketing and hiding the negative … Continue reading Using the courts to protect patients from unapproved stem cell therapies
Stem Cell Stories that Caught Our Eye: New law to protect consumers; using skin to monitor blood sugar; and a win for the good guys
New law targets stem cell clinics that offer therapies not approved by the FDA For some time now CIRM and others around California have been warning consumers about the risks involved in going to clinics that offer stem cell therapies that have not been tested in a clinical trial or approved by the U.S. Food … Continue reading Stem Cell Stories that Caught Our Eye: New law to protect consumers; using skin to monitor blood sugar; and a win for the good guys
How do you know if they really know what they’re saying “yes” to?
How can you not love something titled “Money, Mischief and Science.” It just smacks of intrigue and high stakes. And when the rest of the title is “What Have We Learned About Doing Stem Cell Research?” you have an altogether intriguing topic for a panel discussion. That panel – featuring CIRM’s own Dr. Geoff Lomax, … Continue reading How do you know if they really know what they’re saying “yes” to?